Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.60 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.55 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.55 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.55 |
| ▸ | LDHA | P00338 | 1/20 | 0.55 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.55 |
| ▸ | FBP1 | P09467 | 1/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.55 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.55 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.55 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.55 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.55 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5663970 | 0.90 | ADORA1 (0.69) | TAS1R3TAS1R1ADORA1RXFP1TRPM2 | |
| SCHEMBL1066377 | 0.88 | TAS1R3 (0.75) | TAS1R3TAS1R1ADORA1RXFP1TRPM2 | |
| SCHEMBL8954219 | 0.88 | TAS1R3 (0.75) | TAS1R3TAS1R1ADORA1RXFP1TRPM2 | |
| SCHEMBL29754360 | 0.88 | TAS1R3 (0.75) | TAS1R3TAS1R1ADORA1RXFP1TRPM2 | |
| SCHEMBL11426071 | 0.87 | CA1 (0.58) | TAS1R3TAS1R1ADORA1RXFP1SARS1 | |
| Inosine SCHEMBL5896867 | 0.85 | SLC29A1 (0.67) | ADORA1RXFP1SMN1; SMN2ADORA3ADORA2A | |
| Inosine SCHEMBL5896892 | 0.85 | SLC29A1 (0.67) | ADORA1RXFP1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL28672421 | 0.85 | P2RY1 (0.57) | TAS1R3TAS1R1ADORA1TRPM2DNPH1 | |
| SCHEMBL3505762 | 0.85 | P2RY1 (0.58) | TAS1R3TAS1R1ADORA1TRPM2DNPH1 | |
| SCHEMBL317726 | 0.84 | P2RY1 (0.57) | TAS1R3TAS1R1ADORA1TRPM2DNPH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010053763-A1 | Method and composition for modulating an immune response | INOTEK PHARMACEUTICALS CORPORATION | 2001-12-20 | — | — | US | claimed |
| US-4242505-A | S-Adenosyl-L-methionine compositions and production thereof | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1980-12-30 | — | — | US | claimed |
| JP-54154774-A | — | — | None | — | — | JP | disclosed |
| JP-54109998-A | — | — | None | — | — | JP | disclosed |
| EP-1383505-A4 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | INOTEK PHARMACEUTICALS CORP (US) | 2006-08-09 | — | — | EP | disclosed |
| US-7049301-B2 | Quercetin derivatives and their medical usages | ACADEMY OF MILITARY MEDICAL SCIENCES INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY (CN) | 2006-05-23 | — | — | US | disclosed |
| US-6958324-B2 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | INOTEK PHARMACEUTICALS CORPORATION (US) | 2005-10-25 | — | — | US | disclosed |
| US-20050203052-A1 | Inosine compounds and methods of use thereof | INOTEK PHARMACEUTICALS CORPORATION | 2005-09-15 | — | — | US | disclosed |
| US-20050026078-A1 | Resist compositions including thermal crosslinking agents | CHOI SANG-JUN (KR) | 2005-02-03 | — | — | US | disclosed |
| US-20050014715-A1 | Inosine compounds and their use for treating or preventing an inflammation or reperfusion disease | SALZMAN ANDREW L (US) | 2005-01-20 | — | — | US | disclosed |
| US-6803176-B2 | FORMING PHOTORESIST BY PHOTOLITHOGRAPHY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-10-12 | — | — | US | disclosed |
| US-20040132671-A1 | Quercetin derivatives and their medical usages | ACADEMY OF MILITARY MEDICAL SCIENCES INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY | 2004-07-08 | — | — | US | disclosed |
| EP-1383505-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | Inotek Pharmaceuticals Corporation (US) | 2004-01-28 | — | — | EP | disclosed |
| US-20030054292-A1 | Methods for forming line patterns in semiconductor substrates | CHOI SANG-JUN (KR) | 2003-03-20 | — | — | US | disclosed |
| US-20030040502-A1 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | INOTEK PHARMACEUTICALS CORPORATION | 2003-02-27 | — | — | US | disclosed |
| US-6485895-B1 | Methods for forming line patterns in semiconductor substrates | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2002-11-26 | — | — | US | disclosed |
| WO-2002076400-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | INOTEK PHARMACEUTICALS CORPORATION (US) | 2002-10-03 | — | — | WO | disclosed |
| US-20010053763-A1 | Method and composition for modulating an immune response | INOTEK PHARMACEUTICALS CORPORATION | 2001-12-20 | — | — | US | disclosed |
| US-4242505-A | S-Adenosyl-L-methionine compositions and production thereof | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1980-12-30 | — | — | US | disclosed |
| JP-S54109998-A | COMPOSITION CONTAINING S-ADENOSYL-L-METHIONINE AND ITS PREPARATION | YAMASA SHOYU CO LTD | 1979-08-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132671-A1 | Quercetin derivatives and their medical usages | HTR1A, HTR2A, HTR5A | TAS1R3 952/4885TAS1R1 872/4885ADORA1 78/4885 |
| US-20050203052-A1 | Inosine compounds and methods of use thereof | NOS2, NOS1, ARG2 | TAS1R3 4112/4885TAS1R1 3804/4885ADORA1 185/4885 |
| US-20010053763-A1 | Method and composition for modulating an immune response | SLC11A2, ATP1A2, MSR1 | TAS1R3 3678/4885TAS1R1 3419/4885ADORA1 172/4885 |
| US-20030040502-A1 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | NOS2, NOS1, ARG2 | TAS1R3 2891/4885TAS1R1 2332/4885ADORA1 159/4885 |
| US-20050014715-A1 | Inosine compounds and their use for treating or preventing an inflammation or reperfusion disease | NOS2, NOS1, NOS3 | TAS1R3 3627/4885TAS1R1 3378/4885ADORA1 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.